Literature DB >> 20559909

Genetic evaluation of familial cardiomyopathy.

Daniel P Judge1, Nicole M Johnson.   

Abstract

Hereditary forms of hypertrophic, dilated, restrictive, and right ventricular cardiomyopathies are frequently seen. Patterns of inheritance include autosomal dominant, autosomal recessive, X-linked, and matrilinear. Recognition of the mode of inheritance facilitates proper clinical screening of family members in subsequent generations. Report of successful sequence analysis of the human genome 7 years ago has resulted in widespread translation of genomic information into clinical applications. As technologic advances in high throughput sequence determination continue to evolve, an era of personalized medicine based on genomic data is highly anticipated. Today, clinical genetic testing is available for most monogenic forms of cardiomyopathy and the demand among patients and families is increasing. However, physicians and patients should consider the benefits and limitations of such testing. This review will focus on inherited forms of cardiomyopathy, detailing the currently available genetic tests, as well as benefits, limitations, and possible outcomes of such testing.

Entities:  

Mesh:

Year:  2008        PMID: 20559909     DOI: 10.1007/s12265-008-9025-1

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  88 in total

1.  Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1.

Authors:  J A Jarcho; W McKenna; J A Pare; S D Solomon; R F Holcombe; S Dickie; T Levi; H Donis-Keller; J G Seidman; C E Seidman
Journal:  N Engl J Med       Date:  1989-11-16       Impact factor: 91.245

2.  Connexin43 remodeling caused by inhibition of plakophilin-2 expression in cardiac cells.

Authors:  Eva M Oxford; Hassan Musa; Karen Maass; Wanda Coombs; Steven M Taffet; Mario Delmar
Journal:  Circ Res       Date:  2007-08-02       Impact factor: 17.367

3.  The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy.

Authors:  V V Michels; P P Moll; F A Miller; A J Tajik; J S Chu; D J Driscoll; J C Burnett; R J Rodeheffer; J H Chesebro; H D Tazelaar
Journal:  N Engl J Med       Date:  1992-01-09       Impact factor: 91.245

4.  Natural history of dilated cardiomyopathy due to lamin A/C gene mutations.

Authors:  Matthew R G Taylor; Pamela R Fain; Gianfranco Sinagra; Misi L Robinson; Alastair D Robertson; Elisa Carniel; Andrea Di Lenarda; Teresa J Bohlmeyer; Debra A Ferguson; Gary L Brodsky; Mark M Boucek; Jean Lascor; Andrew C Moss; Wai Lun P Li; Gary L Stetler; Francesco Muntoni; Michael R Bristow; Luisa Mestroni
Journal:  J Am Coll Cardiol       Date:  2003-03-05       Impact factor: 24.094

5.  Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy.

Authors:  Eduardo Garcia-Gras; Raffaella Lombardi; Michael J Giocondo; James T Willerson; Michael D Schneider; Dirar S Khoury; Ali J Marian
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

6.  Improved molecular diagnosis of dystrophin gene mutations using the multiplex ligation-dependent probe amplification method.

Authors:  Marianne Schwartz; Morten Dunø
Journal:  Genet Test       Date:  2004

7.  Desmoglein-2 mutations in arrhythmogenic right ventricular cardiomyopathy: a genotype-phenotype characterization of familial disease.

Authors:  Petros Syrris; Deirdre Ward; Angeliki Asimaki; Alison Evans; Srijita Sen-Chowdhry; Sian E Hughes; William J McKenna
Journal:  Eur Heart J       Date:  2006-11-14       Impact factor: 29.983

8.  Dilated cardiomyopathy and sensorineural hearing loss: a heritable syndrome that maps to 6q23-24.

Authors:  J Schönberger; H Levy; E Grünig; S Sangwatanaroj; D Fatkin; C MacRae; H Stäcker; C Halpin; R Eavey; E F Philbin; H Katus; J G Seidman; C E Seidman
Journal:  Circulation       Date:  2000-04-18       Impact factor: 29.690

9.  Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy.

Authors:  Sara L Van Driest; Vlad C Vasile; Steve R Ommen; Melissa L Will; A Jamil Tajik; Bernard J Gersh; Michael J Ackerman
Journal:  J Am Coll Cardiol       Date:  2004-11-02       Impact factor: 24.094

10.  Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy.

Authors:  Brenda Gerull; Arnd Heuser; Thomas Wichter; Matthias Paul; Craig T Basson; Deborah A McDermott; Bruce B Lerman; Steve M Markowitz; Patrick T Ellinor; Calum A MacRae; Stefan Peters; Katja S Grossmann; Jörg Drenckhahn; Beate Michely; Sabine Sasse-Klaassen; Walter Birchmeier; Rainer Dietz; Günter Breithardt; Eric Schulze-Bahr; Ludwig Thierfelder
Journal:  Nat Genet       Date:  2004-10-17       Impact factor: 38.330

View more
  12 in total

1.  Building a program in translational genomics.

Authors:  Jennifer L Hall
Journal:  J Cardiovasc Transl Res       Date:  2008-11-11       Impact factor: 4.132

Review 2.  Update 2011: clinical and genetic issues in familial dilated cardiomyopathy.

Authors:  Ray E Hershberger; Jill D Siegfried
Journal:  J Am Coll Cardiol       Date:  2011-04-19       Impact factor: 24.094

3.  Late onset sporadic dilated cardiomyopathy caused by a cardiac troponin T mutation.

Authors:  Ana Morales; Jose Renato Pinto; Jill D Siegfried; Duanxiang Li; Nadine Norton; Mark Hofmeyer; Marta Vallin; Azorides R Morales; James D Potter; Ray E Hershberger
Journal:  Clin Transl Sci       Date:  2010-10       Impact factor: 4.689

4.  Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy.

Authors:  Paul A van der Zwaag; Ingrid A W van Rijsingen; Angeliki Asimaki; Jan D H Jongbloed; Dirk J van Veldhuisen; Ans C P Wiesfeld; Moniek G P J Cox; Laura T van Lochem; Rudolf A de Boer; Robert M W Hofstra; Imke Christiaans; Karin Y van Spaendonck-Zwarts; Ronald H Lekanne dit Deprez; Daniel P Judge; Hugh Calkins; Albert J H Suurmeijer; Richard N W Hauer; Jeffrey E Saffitz; Arthur A M Wilde; Maarten P van den Berg; J Peter van Tintelen
Journal:  Eur J Heart Fail       Date:  2012-07-20       Impact factor: 15.534

5.  Optimization of Serum Immunoglobulin Free Light Chain Analysis for Subclassification of Cardiac Amyloidosis.

Authors:  Marc K Halushka; George Eng; A Bernard Collins; Daniel P Judge; Marc J Semigran; James R Stone
Journal:  J Cardiovasc Transl Res       Date:  2015-04-30       Impact factor: 4.132

6.  Use of genetics in the clinical evaluation and management of heart failure.

Authors:  Daniel P Judge; Rosanne Rouf
Journal:  Curr Treat Options Cardiovasc Med       Date:  2010-12

7.  Decreased levels of BAG3 in a family with a rare variant and in idiopathic dilated cardiomyopathy.

Authors:  Arthur M Feldman; Rene L Begay; Tijana Knezevic; Valerie D Myers; Dobromir B Slavov; Weizhong Zhu; Katherine Gowan; Sharon L Graw; Kenneth L Jones; Douglas G Tilley; Ryan C Coleman; Paul Walinsky; Joseph Y Cheung; Luisa Mestroni; Kamel Khalili; Mathew R G Taylor
Journal:  J Cell Physiol       Date:  2014-11       Impact factor: 6.384

Review 8.  Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy.

Authors:  Ray E Hershberger; Jason Cowan; Ana Morales; Jill D Siegfried
Journal:  Circ Heart Fail       Date:  2009-05       Impact factor: 8.790

Review 9.  The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance.

Authors:  Radwa A Noureldin; Songtao Liu; Marcelo S Nacif; Daniel P Judge; Marc K Halushka; Theodore P Abraham; Carolyn Ho; David A Bluemke
Journal:  J Cardiovasc Magn Reson       Date:  2012-02-20       Impact factor: 5.364

10.  Genetic test for dilated and hypertrophic cardiomyopathies: useful or less than useful for patients?

Authors:  F Pastore; V Parisi; R Romano; G Rengo; G Pagano; K Komici; D Leosco
Journal:  Transl Med UniSa       Date:  2013-01-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.